Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.0000769 per share
-
Shares outstanding
-
45.5M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
5.66M
-
Shares change
-
+8.8K
-
Total reported value, excl. options
-
$15.9M
-
Value change
-
-$38.2K
-
Put/Call ratio
-
0.28
-
Number of buys
-
4
-
Number of sells
-
-7
-
Price
-
$2.82
Significant Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q4 2021
18 filings reported holding ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share as of Q4 2021.
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.66M shares
of 45.5M outstanding shares and own 12.43% of the company stock.
Largest 10 shareholders include Knoll Capital Management, LLC (2.48M shares), RA CAPITAL MANAGEMENT, L.P. (2.35M shares), ARK Investment Management LLC (691K shares), RENAISSANCE TECHNOLOGIES LLC (40.1K shares), CITADEL ADVISORS LLC (27.6K shares), GEODE CAPITAL MANAGEMENT, LLC (17.6K shares), BANK OF AMERICA CORP /DE/ (13.9K shares), Altium Wealth Management LLC (11.8K shares), SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC (10.2K shares), and MORGAN STANLEY (5.97K shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.